Palisade Bio, Inc. (PALI) shareholders
Close on Nov 17, 2026Market cap $176.01MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| RA Capital Management, L.P. Joint filing with Peter Kolchinsky (9.90%), Rajeev Shah (9.90%) and 1 more | 17,620,479 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| Rajeev Shah Joint filing with RA Capital Management, L.P. (9.90%), Peter Kolchinsky (9.90%) and 1 more | 15,746,829 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Soleus Capital, LLC Joint filing with Soleus Capital Master Fund, L.P. (8.60%), Soleus Capital Group, LLC (8.60%) and 3 more | 14,996,154 | 8.60% | 13G (passive) amendment | Sep 30, 2026 |
| Janus Henderson Group PLC Joint filing with Janus Henderson Biotech Innovation Master Fund Ltd (6.00%) | 14,885,421 | 9.99% | 13G (passive) | Nov 28, 2025 |
| Perceptive Advisors LLC Joint filing with Joseph Edelman (7.90%), Perceptive Life Sciences Master Fund, Ltd. (7.90%) | 14,113,863 | 7.90% | 13G (passive) amendment | Mar 31, 2026 |
| Michael Kramarz Joint filing with Commodore Capital LP (7.20%), Commodore Capital Master LP (7.20%) and 1 more | 12,366,776 | 7.20% | 13G (passive) amendment | Mar 31, 2026 |
| Point72 Capital Advisors, Inc. Joint filing with Point72 Asset Management, L.P. (7.00%), Steven A. Cohen (7.00%) | 10,495,252 | 7.00% | 13G (passive) amendment | Dec 31, 2025 |
| BlackRock, Inc. | 10,436,760 | 6.00% | 13G (passive) | Jun 30, 2026 |
| Deep Track Capital, LP Joint filing with David Kroin (9.99%), Deep Track Biotechnology Master Fund, Ltd. (6.49%) | 10,012,958 | 9.99% | 13G (passive) | Oct 1, 2025 |
| Commodore Capital LP Joint filing with Commodore Capital Master LP (9.90%), Robert Egen Atkinson (9.90%) and 1 more | 9,690,665 | 9.90% | 13G (passive) | Oct 1, 2025 |
| Octagon Investments Master Fund LP Joint filing with Octagon Capital Advisors LP (6.40%), Ting Jia (6.40%) | 9,567,898 | 6.40% | 13G (passive) | Dec 31, 2025 |
| Franklin Advisers, Inc. Joint filing with Franklin Resources, Inc. (6.00%) | 9,163,990 | 6.00% | 13G (passive) | Dec 31, 2025 |
| Vanguard Capital Management | 8,995,805 | 5.16% | 13G (passive) | Sep 30, 2026 |
| Columbia Management Investment Advisers, LLC Joint filing with Ameriprise Financial, Inc. (5.30%) | 8,711,385 | 5.30% | 13G (passive) | Mar 31, 2026 |
| Matthew Sesterhenn Joint filing with Squadron Capital Management LLC (8.50%), William Blank (8.50%) and 1 more | 8,250,000 | 8.50% | 13G (passive) | Oct 1, 2025 |
| Armistice Capital, LLC Joint filing with Steven Boyd (9.99%) | 285,417 | 9.99% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PALI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | 13,063,687 | 7.50% | $27.30M | New | 0.94% |
| B Group, Inc. | 11,414,285 | 6.55% | $23.86M | – | 11.20% |
| Ameriprise Financial Inc | 11,081,434 | 6.36% | $23.16M | −428,886 | 0.00% |
| Jupiter Topco LLC | 10,689,452 | 6.13% | $22.39M | New | 0.01% |
| BlackRock, Inc. | 10,436,760 | 5.99% | $21.81M | +8,560,420 | 0.00% |
| Octagon Capital Advisors LP | 10,276,317 | 5.90% | $21.48M | – | 1.93% |
| Perceptive Advisors LLC | 8,425,065 | 4.83% | $17.61M | −503,084 | 0.26% |
| Ra Capital Management, L.P. | 7,124,116 | 4.09% | $14.89M | – | 0.13% |
| Franklin Resources Inc | 5,785,189 | 3.32% | $12.09M | – | 0.00% |
| Point72 Asset Management, L.P. | 5,253,403 | 3.01% | $10.98M | +4,841,631 | 0.01% |
| Boxer Capital Management, LLC | 4,799,875 | 2.75% | $10.03M | – | 0.76% |
| Adage Capital Partners Gp, L.L.C. | 4,500,000 | 2.58% | $9.41M | – | 0.01% |
| Eversept Partners, LP | 4,182,785 | 2.40% | $8.74M | −804,714 | 0.45% |
| Geode Capital Management, LLC | 3,760,485 | 2.16% | $7.86M | +2,214,245 | 0.00% |
| Wellington Management Group Llp | 3,703,936 | 2.13% | $7.74M | +799,025 | 0.00% |
| Goldman Sachs Group Inc | 3,578,020 | 2.05% | $7.48M | −1,795,931 | 0.00% |
| Federated Hermes, Inc. | 3,136,607 | 1.80% | $6.56M | – | 0.01% |
| Squadron Capital Management LLC | 3,000,000 | 1.72% | $6.27M | – | 1.95% |
| Propel Bio Management, LLC | 2,582,388 | 1.48% | $5.40M | +1,467,388 | 2.82% |
| Vestal Point Capital, LP | 2,500,000 | 1.43% | $5.23M | – | 0.12% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 124 | 173M | 99.5% | 50 / 33 | 24 / 21 | 58M | 23M |
| Q1 2026 | 96 | 149M | 85.8% | 31 / 30 | 25 / 20 | 49M | 34M |
| Q4 2025 | 86 | 136M | 78.0% | 75 / 7 | 1 / 1 | 136M | 0M |
| Q3 2025 | 12 | 0M | 0.1% | 2 / 7 | 1 / 1 | 0M | 0M |
| Q2 2025 | 11 | 0M | 0.0% | 3 / 2 | 3 / 5 | 0M | 0M |
| Q1 2025 | 13 | 0M | 0.2% | 4 / 5 | 1 / 1 | 0M | 0M |
| Q4 2024 | 10 | 0M | 0.1% | 2 / 4 | 1 / 1 | 0M | 0M |
| Q3 2024 | 9 | 0M | 0.1% | 1 / 3 | 1 / 0 | 0M | 0M |
| Q2 2024 | 8 | 0M | 0.0% | 8 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
62 funds held PALI in Q2 2026, 50% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PALI | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Russell 2000 ETF | 3,729,134 | 2.14% | $7.79M | 0.01% | Jun 30, 2026 |
| Federated Hermes Kaufmann Small Cap Fund | 3,136,607 | 1.80% | $5.94M | 0.21% | Jul 31, 2026 |
| Franklin Biotechnology Discovery Fund | 2,119,910 | 1.22% | $4.02M | 0.35% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1,722,817 | 0.99% | $3.60M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,610,025 | 0.92% | $3.05M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 1,117,624 | 0.64% | $2.34M | 0.02% | Jun 30, 2026 |
| Nuveen Equity Index Fund | 773,196 | 0.44% | $1.47M | 0.00% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 667,004 | 0.38% | $1.41M | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 495,848 | 0.28% | $1.04M | 0.07% | Jun 30, 2026 |
| Simplify Propel Opportunities ETF | 450,543 | 0.26% | $941.63K | 1.22% | Jun 30, 2026 |
| iShares Core S&P Total U.S. Stock Market ETF | 380,673 | 0.22% | $795.61K | 0.00% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 358,983 | 0.21% | $680.27K | 0.01% | Jul 31, 2026 |
| Master Small Cap Index Series | 275,899 | 0.16% | $576.63K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 269,212 | 0.15% | $570.73K | 0.00% | May 31, 2026 |
| iShares Russell 2000 Growth ETF | 246,405 | 0.14% | $514.99K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John David Finley | CEO CFO, Director | 2,033,141 | 1.17% | Oct 7, 2026 |
| Julien E. Capers | See Remarks | 787,300 | 0.45% | Oct 21, 2026 |
| Mitchell Lawrence Jones | See Remarks | 1,683,757 | 0.97% | Oct 7, 2026 |
| Donald Allen Williams | Director | 1,593,294 | 0.91% | Oct 5, 2026 |
| Robert Baltera Jr. | Director | 461,904 | 0.27% | Jul 10, 2026 |
| Binxian Wei | Director | 613,355 | 0.35% | Jun 12, 2026 |
| Emil Chuang | Director | 612,500 | 0.35% | Jun 12, 2026 |
| Jordan Michael Zwick | Director | 336,904 | 0.19% | Jun 12, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Julien E. Capers See Remarks | Oct 19, 2026 | Award | +787,300 | – | – | 787,300 |
| Mitchell Lawrence Jones See Remarks | Oct 6, 2026 | Tax withholding | −1,031,102 | $1.49 | $1.54M | 1,683,757 |
| Mitchell Lawrence Jones See Remarks | Oct 6, 2026 | Option exercise | +2,620,850 | – | – | 2,714,859 |
| John David Finley CEO CFO, Director | Oct 6, 2026 | Tax withholding | −1,411,982 | $1.49 | $2.10M | 1,944,690 |
| John David Finley CEO CFO, Director | Oct 6, 2026 | Option exercise | +3,227,384 | – | – | 3,356,672 |
| Donald Allen Williams Director | Oct 2, 2026 | Buy | +10,000 | $1.46 | $14.60K | 1,590,294 |
| Donald Allen Williams Director | Oct 1, 2026 | Buy | +10,000 | $1.42 | $14.20K | 1,580,294 |
| John David Finley CEO, CFO, Director | Aug 19, 2026 | Gift | −88,400 | – | – | 129,288 |
| John David Finley CEO, CFO, Director | Aug 19, 2026 | Gift | +88,400 | – | – | 88,451 |
| Robert Baltera Jr. Director | Jul 9, 2026 | Buy | +25,000 | $1.96 | $49.00K | 461,904 |
| Robert Baltera Jr. Director | Jul 8, 2026 | Buy | +20,000 | $1.99 | $39.80K | 436,904 |
| John David Finley CEO, CFO, Director | Jul 7, 2026 | Sale | −146,798 | $2.07 | $303.87K | 217,555 |
| John David Finley CEO, CFO, Director | Jul 7, 2026 | Option exercise | +133 | $0.70 | $93 | 217,688 |
| Robert Baltera Jr. Director | Jul 7, 2026 | Buy | +30,000 | $2.03 | $60.90K | 416,904 |
| Mitchell Lawrence Jones Chief Medical Officer | Jul 7, 2026 | Sale | −51,880 | $2.05 | $106.35K | 94,009 |
| John David Finley CEO, CFO, Director | Jul 6, 2026 | Option exercise | +335,167 | – | – | 364,353 |
| Robert Baltera Jr. Director | Jul 6, 2026 | Buy | +20,000 | $2.05 | $41.00K | 386,904 |
| Mitchell Lawrence Jones Chief Medical Officer | Jul 6, 2026 | Option exercise | +131,167 | – | – | 145,889 |
| Robert Baltera Jr. Director | Jul 2, 2026 | Buy | +10,000 | $1.98 | $19.80K | 366,904 |
| Robert Baltera Jr. Director | Jul 1, 2026 | Buy | +20,000 | $1.98 | $39.60K | 356,904 |
| Robert Baltera Jr. Director | Jun 10, 2026 | Award | +336,904 | – | – | 336,904 |
| Jordan Michael Zwick Director | Jun 10, 2026 | Award | +336,904 | – | – | 336,904 |
| Donald Allen Williams Director | Jun 10, 2026 | Award | +1,498,900 | – | – | 1,509,628 |
| Donald Allen Williams Director | Jun 10, 2026 | Option exercise | +60,666 | – | – | 1,570,294 |
| Emil Chuang Director | Jun 10, 2026 | Option exercise | +20,200 | – | – | 612,500 |
| Emil Chuang Director | Jun 10, 2026 | Award | +592,300 | – | – | 592,300 |
| Binxian Wei Director | Jun 10, 2026 | Option exercise | +20,200 | – | – | 613,355 |
| Binxian Wei Director | Jun 10, 2026 | Award | +592,300 | – | – | 593,155 |
| Mitchell Lawrence Jones Chief Medical Officer | Feb 12, 2026 | Sale | −1,989 | $1.75 | $3.48K | 13,263 |
| John David Finley CEO, CFO, Director | Feb 12, 2026 | Sale | −3,896 | $1.75 | $6.82K | 27,353 |
| Mitchell Lawrence Jones Chief Medical Officer | Feb 11, 2026 | Option exercise | +8,000 | – | – | 15,252 |
| John David Finley CEO, CFO, Director | Feb 11, 2026 | Option exercise | +13,333 | – | – | 31,249 |
| Donald Allen Williams Director | Jan 16, 2026 | Buy | +5,000 | $1.67 | $8.35K | 10,728 |
| Donald Allen Williams Director | Jan 9, 2026 | Buy | +5,000 | $1.88 | $9.40K | 5,728 |
| Binxian Wei Director | Nov 21, 2024 | Option exercise | +388 | – | – | 855 |
| Donald Allen Williams Director | Nov 21, 2024 | Option exercise | +388 | – | – | 728 |
| Donald Allen Williams Director | Jun 11, 2024 | Option exercise | +340 | – | – | 340 |
| Binxian Wei Director | Jun 11, 2024 | Option exercise | +465 | – | – | 467 |
| John David Finley CEO, CFO, Director | May 28, 2024 | Option exercise | +2,111 | – | – | 14,079 |
| John David Finley CEO, CFO, Director | May 28, 2024 | Option exercise | +1,622 | – | – | 10,059 |
| John David Finley CEO, CFO, Director | May 28, 2024 | Tax withholding | −467 | $4.76 | $2.22K | 9,592 |
| John David Finley CEO, CFO, Director | May 28, 2024 | Option exercise | +3,335 | – | – | 12,927 |
| John David Finley CEO, CFO, Director | May 28, 2024 | Tax withholding | −959 | $4.76 | $4.56K | 11,968 |
| John David Finley CEO, CFO, Director | May 28, 2024 | Tax withholding | −607 | $4.76 | $2.89K | 13,472 |
| Mitchell Lawrence Jones Chief Medical Officer | May 28, 2024 | Tax withholding | −461 | $4.76 | $2.19K | 3,852 |
| Mitchell Lawrence Jones Chief Medical Officer | May 28, 2024 | Option exercise | +2,735 | – | – | 3,568 |
| Mitchell Lawrence Jones Chief Medical Officer | May 28, 2024 | Tax withholding | −810 | $4.76 | $3.86K | 2,758 |
| Mitchell Lawrence Jones Chief Medical Officer | May 28, 2024 | Option exercise | +1,555 | – | – | 4,313 |
| Donald Allen Williams Director | May 28, 2024 | Buy | +1,000 | $4.86 | $4.86K | 1,000 |
| John David Finley CEO, CFO, Director | May 24, 2024 | Buy | +1,000 | $4.81 | $4.81K | 8,437 |
| John David Finley CEO, CFO, Director | May 20, 2024 | Award | +666 | $4.97 | $3.31K | 7,437 |
| Mitchell Lawrence Jones CEO, CFO, Director | May 6, 2024 | Tax withholding | −90 | $8.46 | $761 | 724 |
| Mitchell Lawrence Jones CEO, CFO, Director | May 6, 2024 | Option exercise | +156 | – | – | 880 |
| Mitchell Lawrence Jones CEO, CFO, Director | May 6, 2024 | Tax withholding | −47 | $8.46 | $398 | 833 |
| Mitchell Lawrence Jones CEO, CFO, Director | May 6, 2024 | Option exercise | +304 | – | – | 814 |
| John David Finley CEO, CFO, Director | May 6, 2024 | Tax withholding | −67 | $8.46 | $567 | 6,621 |
| John David Finley CEO, CFO, Director | May 6, 2024 | Option exercise | +211 | – | – | 6,832 |
| John David Finley CEO, CFO, Director | May 6, 2024 | Tax withholding | −61 | $8.46 | $516 | 6,771 |
| John David Finley CEO, CFO, Director | May 6, 2024 | Option exercise | +232 | – | – | 6,688 |
| John David Finley CEO, CFO, Director | Mar 11, 2024 | Option exercise | +5,558 | – | – | 96,849 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Palisade Bio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 195,218 shares on Sep 22, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| John David Finley Officer | Jul 7, 2026 | 146,798 | $303.34K | Jul 7, 2026 | RSU Vesting |
| Mitchell Lawrence Jones Officer | Jul 7, 2026 | 53,000 | $108.12K | Jul 7, 2026 | RSU |
See a number that looks wrong?